Product Details

Visita Plus+++

Betamethasone; Clotrimazole; Neomycin sulfate
0.05%; 1%; 0.35%
Cream

ROA

Topical

Applicant Name

Elbe Pharma Nigeria Limited

NRN

B4-4845

Status

Active


Composition

Visita Plus contains: Clotrimazole BP 1.0% w/w, Betamethasone Dipropionate USP Equivalent to Betamethasone 0.05 % w/w, Neomycin Sulfate USP 0.50 % w/w Equivalent to Neomycin Base 0.35 % w/w in a Cream Base Excipients: Chlorocresol, Cetomacrogol -1000, Cetostearyl Alcohol, Light Liquid Paraffin, White Soft Paraffin, Propylene Glycol, lsopropyl Myristate BP, Citric Acid Anhydrous BP, Fragrance Soft Petal AF 1023 BP, Purified Water BP  

ATC Code

D07CC01  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 × 30 g (in LAMI Tube)  

Product Description

Topical, semi-solid dosage form - cream A white soft homogeneous cream, free from gritty particles VISITA PLUS CLOTRIMAZOLE 1.0%W/W, BETAMETHAZONE DIPROPIONATE 0.05%W/W, NEOMYCIN SULPHATE 0.5%W/W VISITA PLUS (CLOTRIMAZOLE 1.0% W/W, BETAMETHAZONE DIPROPIONATE 0.05% W/W, NEOMYCIN SULPHATE 0.5% W/W) B4-4845 Drugs Imported Products 1X30G Prescription Only Medicine (POM) 16/12/2022 ELBE PHARMA NIGERIA LIMITED, 1, AFRICAN CHURCH CLOSE, OFF COKER ROAD, ILUPEJU, LAGOS STATE, NIGERIA. 8069718539 elbepharma.rgn@gmail.com S. KANT HEALTHCARE LTD, 1802-1805, GIDC, PHASE 111, VAPI 396 195, GUJARAT, INDIA, India

Manufacturer Name

S Kant Healthcare Ltd

Manufacturer Country

INDIA  

Approval Date

2023-04-26  

Expiry Date

2028-04-25